BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Torisel® (temsirolimus): Fragments of glass possibly present in the diluent

Active substance: temsirolimus

Important information on the possible presence of fragments of glass in batches AGBV/99 and AGQQ/13 of vials of the diluent Torisel® and recommended measures.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 2MB, File is accessible